About this Journal Submit a Manuscript Table of Contents
ISRN Rheumatology
Volume 2012 (2012), Article ID 765380, 8 pages
http://dx.doi.org/10.5402/2012/765380
Clinical Study

High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?

Division of Pediatric Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA

Received 8 September 2011; Accepted 3 October 2011

Academic Editor: C. J. Chen

Copyright © 2012 Sukesh Sukumaran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Adriano Magli, Raimondo Forte, Pasqualina Navarro, Giustina Russo, Francesca Orlando, Loredana Latanza, and Maria Alessio, “Adalimumab for juvenile idiopathic arthritis-associated uveitis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 6, pp. 1601–1606, 2013. View at Publisher · View at Google Scholar
  • Randy Q. Cron, “Treatment of Juvenile Idiopathic Arthritis in the Biologic Age,” Rheumatic Disease Clinics of North America, vol. 39, no. 4, pp. 751–+, 2013. View at Publisher · View at Google Scholar
  • Sibel Kadayifcilar, and Seza Ozen, “Rheumatic Inflammatory Eye Diseases of Childhood,” Rheumatic Disease Clinics of North America, vol. 39, no. 4, pp. 801–+, 2013. View at Publisher · View at Google Scholar
  • Ajay Tambralli, Timothy Beukelman, Peter Weiser, Thomas Prescott Atkinson, and Matthew Laurence Stoll, “High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis,” Journal of Rheumatology, vol. 40, no. 10, pp. 1749–1755, 2013. View at Publisher · View at Google Scholar
  • Daniel H. Solomon, “Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?,” Journal of Rheumatology, vol. 40, no. 10, pp. 1643–1645, 2013. View at Publisher · View at Google Scholar
  • Jonathan N. Kruh, Paul Yang, and Ana M. Suelves, “Infliximab for the Treatment of Refractory Noninfectious Uveitis A Study of 88 Patients with Long-term Follow-up,” Ophthalmology, vol. 121, no. 1, pp. 358–364, 2014. View at Publisher · View at Google Scholar